Literature DB >> 15381370

Evolution of 8p loss in transformed human prostate epithelial cells.

Jill A Macoska1, Pamela Paris, Colin Collins, Armann Andaya, Ben Beheshti, Hassan Chaib, Rajiv Kant, Lesa Begley, James W MacDonald, Jeremy A Squire.   

Abstract

Deletion or rearrangement of sequences that map to the short arm of chromosome 8 (8p) are frequently associated with human prostate tumorigenesis. These losses often involve the entire short arm of chromosome 8 or very large regions of distal or proximal 8p, and several putative tumor suppressor genes mapping to 8p have been described. However, the mechanism responsible for 8p loss during prostate tumorigenesis has not been elucidated. In this study, we report data obtained using array comparative genomic hybridization and spectral karyotyping, which demonstrate successive translocation and deletion events responsible for loss of one copy of 8p in transformed human prostate epithelial cells. Moreover, this loss was accompanied by a pronounced transcriptional downregulation of genes mapping to the remaining copy of 8p and enhanced expression of traits associated with neoplastic transformation. Taken together, these studies illustrate a potential mechanism and functional role for 8p loss in human prostate tumorigenesis.

Entities:  

Mesh:

Year:  2004        PMID: 15381370     DOI: 10.1016/j.cancergencyto.2004.02.013

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

1.  Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer.

Authors:  Pamela L Paris; Matthias D Hofer; Giancarlo Albo; Rainer Kuefer; Juergen E Gschwend; Richard E Hautmann; Jane Fridyland; Jeffrey Simko; Peter R Carroll; Mark A Rubin; Colin Collins
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

2.  The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy.

Authors:  L A Begley; S Kasina; J MacDonald; J A Macoska
Journal:  Cytokine       Date:  2008-06-24       Impact factor: 3.861

3.  Leukocytic promotion of prostate cellular proliferation.

Authors:  Kristy L McDowell; Lesa A Begley; Nirit Mor-Vaknin; David M Markovitz; Jill A Macoska
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

4.  ADAM-mediated amphiregulin shedding and EGFR transactivation.

Authors:  S Kasina; P A Scherle; C L Hall; J A Macoska
Journal:  Cell Prolif       Date:  2009-09-07       Impact factor: 6.831

5.  Genome abnormalities precede prostate cancer and predict clinical relapse.

Authors:  Yan P Yu; Chi Song; George Tseng; Bao Guo Ren; William LaFramboise; George Michalopoulos; Joel Nelson; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2012-05-07       Impact factor: 4.307

6.  CXCL5 promotes prostate cancer progression.

Authors:  Lesa A Begley; Sathish Kasina; Rohit Mehra; Shreelekha Adsule; Andrew J Admon; Robert J Lonigro; Arul M Chinnaiyan; Jill A Macoska
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

7.  Genomic Copy Number Variations in the Genomes of Leukocytes Predict Prostate Cancer Clinical Outcomes.

Authors:  Yan P Yu; Silvia Liu; Zhiguang Huo; Amantha Martin; Joel B Nelson; George C Tseng; Jian-Hua Luo
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

8.  CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling.

Authors:  José A Rodríguez-Nieves; Susan C Patalano; Diego Almanza; Mehrnaz Gharaee-Kermani; Jill A Macoska
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

9.  CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.

Authors:  Mehrnaz Gharaee-Kermani; Sathish Kasina; Bethany B Moore; Dafydd Thomas; Rohit Mehra; Jill A Macoska
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

10.  SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines.

Authors:  Francesca Demichelis; Heidi Greulich; Jill A Macoska; Rameen Beroukhim; William R Sellers; Levi Garraway; Mark A Rubin
Journal:  Nucleic Acids Res       Date:  2008-02-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.